• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    Trending Down-0.0001 (-50.0000%)
  • Bid / Lots
    0.0001/ 4,834,659
  • Ask / Lots
    0.0002/ 1,579,492
  • Open / Previous Close
    0.0002 / 0.0002
  • Day Range
    Low 0.0001
    High 0.0002
  • 52 Week Range
    Low 0.0001
    High 0.0007
  • Volume
    28,225,000
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.0002
TimeVolumeBIEL
09:32 ET117000000.0002
09:39 ET1025000.0001
10:19 ET100000.0002
10:26 ET3000000.0001
11:02 ET300000.0001
11:27 ET750000.00015
11:54 ET75000000.0002
01:17 ET48950000.0001
01:55 ET25000000.0002
02:38 ET1125000.00015
02:54 ET10000000.0001
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBIEL
BioElectronics Corp
4.9M
-5.0x
---
United StatesOHCS
Optimus Healthcare Services Inc
3.2M
-0.4x
---
United StatesTIVC
Tivic Health Systems Inc
1.6M
0.0x
---
United StatesHLTT
Healthtech Solutions Inc
48.1K
0.0x
---
United StatesBGMD
BG Medicine Inc
10.0
0.0x
---
United StatesDYXC
DiaSys Corp
510.0
0.0x
---
As of 2024-04-26

Company Information

BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy, is developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The Company is also focused on international customers to expand its distributions and sales. The neuromodulation basis of PSWT presents significant opportunities for it to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.

Contact Information

Headquarters
4539 Metropolitan CtFREDERICK, MD, United States 21704-9452
Phone
301-874-4890
Fax
301-874-6935

Executives

Chairman of the Board
Richard Staelin
President, Chief Executive Officer, Treasurer, Director
Kelly Whelan
Vice President - Sales, Director
Keith Nalepka
Vice President - Engineering
John Martinez
Vice President - Production
William Monn

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.9M
Revenue (TTM)
$1.6M
Shares Outstanding
24.7B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.85
EPS
$0.00
Book Value
$0.00
P/E Ratio
-5.0x
Price/Sales (TTM)
3.1
Price/Cash Flow (TTM)
---
Operating Margin
-9.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.